Applied Nanotech Holdings, Inc. is pleased to announce that it has been notified that it has been selected for a SBIR Phase II award to develop carbon foils for the next generation ion beam accelerators. The amount of the award is approximately $750,000.
Tekmira Pharmaceuticals Corporation, a leader in RNA interference (RNAi) therapeutics, today announced that its Investigational New Drug (IND) application for TKM-PLK1 has been cleared by the United States Food and Drug Administration (FDA) allowing Tekmira to initiate a Phase 1 human clinical trial.
The eBeam Initiative, a forum dedicated to the education and promotion of a new design-to-manufacturing approach known as design for e-beam (DFEB), today announced that several of its members will jointly present the latest breakthroughs in DFEB mask technology at the Annual SPIE/BACUS Symposium 2010 - a worldwide technical conference and exhibition and premier event for the photomask industry.
At this year's Composites Europe show from September 14 through 16 in Essen FutureCarbon GmbH, the leading producer of super-composite materials, is presenting its latest solutions for heating systems in hall 10-11 on booth G36.
Particle Sciences Inc. (PSI), a leading pharmaceutical Contract Research Organization (CRO), has been engaged by Children's Hospital Boston to help advance early stage molecules and drug innovations into new therapeutic products for patient care.
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation in life sciences and soft matter announces the Vortis Advanced, the new standard in SPM Control systems with the lowest noise and highest signal speeds seen to date.